期刊文献+

基于Excel函数设计抗菌药物间歇静脉滴注给药方案 被引量:2

Excel-based Design of Intermittent Intravenous Drip Dose Regimen of Antibiotics
原文传递
导出
摘要 目的:设计抗菌药物间歇静脉滴注给药方案。方法:以头孢唑啉钠、头孢曲松钠、阿米卡星为例,采用多剂量函数法处理相关药动学数据,将药动学与药效学(PK/PD)参数相结合,应用Excel软件编写计算程序,设计合理给药方案。结果:时间依赖性抗菌药物的杀菌效应主要取决于血药浓度高于细菌最低抑菌浓度(MIC)的时间;对于血浆消除半衰期短的抗菌药物宜采取小剂量均匀分次给药,甚至持续给药;半衰期较长者12~24h给药1次即可。浓度依赖性抗菌药物优化临床抗菌疗效的最佳PK/PD参数为Cmax/MIC,适宜日剂量单次给予。结论:基于PK/PD,应用Excel函数设计抗菌药物间歇静脉滴注给药方案,方法简便、可靠、直观。 OBJECTIVE: To design intermittent intravenous drip dose regimen of antibiotics. METHODS: The pharmacokinetic data were computed using the multidoses function method taking cefazolin, ceftriaxone and amikacin as examples. Then computation program was programmed using Excel software based on pharmacokinetic parameters combined with pharmacodynamic parameters to design rational dosage regimen. RESULTS: The bactericidal effect of time- dependent antibiotics was chiefly dependent on the time during which the drug blood concentration was higher than minimal inhibitory concentration (MIC) .For those antibacterials with short elimination half life(t 1/2)in plasma, the best regimen was to give patients the medicine in a small average divided dose or continuous medication. For those with(t 1/2) greater than 12--24 h, single dose administration was advisable. For concentration-dependent antibiotics, the best PK/ PD parameters for optimal clinical antibiotic effect were Cmax/ M IC, and which should be administered in single time (daily dose). CONCLUSION: PK/PD parameters - based intermittent intravenous drip dosage regimen of antibiotics designed by means of Excel function is simple, reliable and intuitionistic.
出处 《中国药房》 CAS CSCD 北大核心 2009年第29期2311-2314,共4页 China Pharmacy
基金 黑龙江省教育厅科学技术研究项目(11513062)
关键词 抗菌药物 多剂量函数法 间歇静脉滴注 药动学与药效学参数 EXCEL Antibiotics Multidoses function method Intermittent intravenous drip Pharmacokinetic and pharmacodynamic parameters Excel
  • 相关文献

参考文献5

二级参考文献10

  • 1刘学红,郭瑞臣,黄明慧.抗菌药物的药动学和药效学参数对临床用药的意义[J].中国医院药学杂志,2005,25(2):154-155. 被引量:77
  • 2[1] David RL,Lehman D,Sitdley CA,et al.Am ikacin pharmacokinetics in patients receiving high-dose cancer chemotherapy.A ntimicrob Agents Chemother1991,35(5):944.
  • 3[2] Kaojarern S,Maoleekoonpairoj S,Atichartak arn V.Pharmacokinetics of amikacin in hematolgic malignancies,Antimicrob Agent s Chemother,1989,33(8):1406.
  • 4[3] Isaksson B,Nilsson L,Maller R,et al.P ostantibiotic effect of aminoglycosides on gram-negative bacteria evaluated by a new method,J antimicrob Chemother,1988,22:23.
  • 5[4] Isaksson B,Hanberger H,Maller R,et al. The postantibiotics effect of amikacin alone and in combination with piperacil lin on gram-negative bacteria.Scand J Infect Suppl,1990,74:129.
  • 6Xiao YH.Research and clinical application of antibiotic pharmacodynamics (1). Chin J Clin Pharmacol, 2002,4:310-316.肖永红.抗生素药效学研究与临床应用(1). 中国临床药理杂志, 2002,4:310-316.
  • 7Ambrose PG, Quintiliani R, Nightingale CH, et al. Continuous vs intermittent infusion of cefuroxime for the treatment of community aquired pneumonia. Infect Dis Clin Prac ,1998,7:463-470.
  • 8Nicolau DP, Freeman CD, Belliveau PP, et al. Experience with a once-daily aminoglycoside program administered to 2184 adult patients. Antimicrob Agent Chemother, 1995,39:650-655.
  • 9Kenneth Yen,Christine Walsh-Kelly,Halim Hennes.Feasibility survey for a study on selective antibiotic management of acute otitis media[J].Wisconsin medical journal,2001,100(8):58.
  • 10李燕,赵真玲.抗菌药物超MIC时间(T>MIC)药动学评价[J].儿科药学,2000,6(4):3-4. 被引量:9

共引文献55

同被引文献18

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部